Advertisement
Screener

REPLIMUNE GROUP, INC. (REPL) Auditor

REPLIMUNE GROUP, INC. Auditor

The independent registered public accounting firm that signed the audit report in each annual report on Form 10-K, newest first. PCAOB firm ID and the internal-control attestation are as tagged on the cover from fiscal 2021; earlier rows come from the signed report text.

  • 2026-06-29: Fiscal year end 2026-03-31; Auditor PricewaterhouseCoopers LLP; PCAOB firm ID 238; Location Florham Park, New Jersey.
  • 2025-05-22: Fiscal year end 2025-03-31; Auditor PricewaterhouseCoopers LLP; PCAOB firm ID 238; Location Boston, Massachusetts.
  • 2024-05-16: Fiscal year end 2024-03-31; Auditor PricewaterhouseCoopers LLP; PCAOB firm ID 238; Location Boston, Massachusetts.
  • 2023-05-18: Fiscal year end 2023-03-31; Auditor PricewaterhouseCoopers LLP; PCAOB firm ID 238; Location Boston, Massachusetts.
FiledFiscal year endAuditorPCAOB firm IDLocationInternal-control attestation
2026-06-292026-03-31PricewaterhouseCoopers LLP238Florham Park, New JerseyNo
2025-05-222025-03-31PricewaterhouseCoopers LLP238Boston, MassachusettsNo
2024-05-162024-03-31PricewaterhouseCoopers LLP238Boston, MassachusettsNo
2023-05-182023-03-31PricewaterhouseCoopers LLP238Boston, MassachusettsNo
2022-05-192022-03-31PricewaterhouseCoopers LLP238Boston, MassachusettsNo
2021-05-202021-03-31PricewaterhouseCoopers LLPBoston, Massachusetts
2020-06-032020-03-31PricewaterhouseCoopers LLPBoston, Massachusetts
2019-06-282019-03-31PricewaterhouseCoopers LLPBoston, Massachusetts

Similar stocks

Stock NameCountryMarket CapPE Ratio
Vor Biopharma Inc. (VOR)United States$1.091B1.60
MeiraGTx Holdings plc (MGTX)United States$1.061B16.10
Monte Rosa Therapeutics, Inc. (GLUE)United States$1.002B-12.81
Cullinan Therapeutics, Inc. (CGEM)United States$0.993B-5.72
Odyssey Therapeutics, Inc. (ODTX)United States$0.960B
Maze Therapeutics, Inc. (MAZE)United States$1.457B-12.40
Inhibrx Biosciences, Inc. (INBX)United States$1.477B-10.08
Sana Biotechnology, Inc. (SANA)United States$0.886B-4.92
Candel Therapeutics, Inc. (CADL)United States$0.885B-8.86
Attovia Therapeutics, Inc. (ATTO)United States$0.828B